Cargando…

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

Detalles Bibliográficos
Autor principal:	Zuurbier, Coert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501646/ https://www.ncbi.nlm.nih.gov/pubmed/32950054 http://dx.doi.org/10.1186/s12933-020-01119-z

Ejemplares similares

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

Does blood transfusion harm cardiac surgery patients?
por: Murphy, Gavin J
Publicado: (2009)

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
por: Uthman, Laween, et al.
Publicado: (2018)

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions
por: Zuurbier, Coert J, et al.
Publicado: (2021)

Commentary: Radical cardiac weight reduction
por: Woods, Ronald K.
Publicado: (2021)

Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus
por: Eroglu, Talip E, et al.
Publicado: (2022)

Glucose-Insulin Therapy, Plasma Substrate Levels and Cardiac Recovery After Cardiac Ischemic Events
por: Zuurbier, C. J., et al.
Publicado: (2008)

Does acupuncture reduce the risk of acute myocardial infarction?
por: Leem, Jungtae
Publicado: (2016)

Cardiac metabolism as a driver and therapeutic target of myocardial infarction
por: Zuurbier, Coert J., et al.
Publicado: (2020)

An exploration of the experience of dapagliflozin in clinical practice
por: Anitha, Anuba Paulvarnan, et al.
Publicado: (2022)

Appropriate Dose of Dapagliflozin Improves Cardiac Outcomes by Normalizing Mitochondrial Fission and Reducing Cardiomyocyte Apoptosis After Acute Myocardial Infarction
por: Fan, Zhong-guo, et al.
Publicado: (2022)

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
por: Xiao, Yang, et al.
Publicado: (2021)

Dapagliflozin‐lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice
por: Åstrand, Annika, et al.
Publicado: (2017)

Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction
por: Ortega‐Paz, Luis, et al.
Publicado: (2022)

Role of salivary cardiac troponin I in acute myocardial infarction
por: Vijayvergiya, Rajesh
Publicado: (2013)

Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausible
por: Gilbert, Richard E., et al.
Publicado: (2019)

Exercise regulates cardiac metabolism: Sex does matter
por: Yang, Tingting, et al.
Publicado: (2022)

Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits
por: Baartscheer, Antonius, et al.
Publicado: (2016)

Commentary: The far-out prospect of cardiac regeneration after myocardial infarction
por: Kilmarx, Sumner E., et al.
Publicado: (2021)

Mitochondrial function in macrophages controls cardiac repair after myocardial infarction
por: Weissman, David, et al.
Publicado: (2023)

Blood glucose levels and bodyweight change after dapagliflozin administration
por: Kim, Hyunah, et al.
Publicado: (2021)

Invasive surgery reduces infarct size and preserves cardiac function in a porcine model of myocardial infarction
por: van Hout, Gerardus PJ, et al.
Publicado: (2015)

Cardiac MRI detection of infarct size reduction with hypothermia in porcine ischemia reperfusion injury model
por: Dash, Rajesh, et al.
Publicado: (2015)

Post-infarction cardiac remodeling—differential biomarkers for left atrial and left ventricular remodeling
por: Selejan, Simina-Ramona, et al.
Publicado: (2021)

Towards an improved definition of periprocedural myocardial infarction: The role of high‐sensitivity cardiac troponins
por: Heuts, Samuel, et al.
Publicado: (2021)

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
por: Tsai, Kun-Ling, et al.
Publicado: (2021)

Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Does anesthetic provide similar neuroprotection to therapeutic hypothermia after cardiac arrest?
por: Zhang, Hong
Publicado: (2010)

Systemic inflammatory response to cardiac surgery: does female sex really protect?
por: Seghaye, Marie-Christine, et al.
Publicado: (2001)

Does GLP-1 suppress hepatocyte glucose production directly, via fibroblast growth factor 21?
por: Liu, Jun-Li, et al.
Publicado: (2019)

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
por: Chen, Sha, et al.
Publicado: (2023)

Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy
por: Balcıoğlu, Akif Serhat, et al.
Publicado: (2022)

Myocardial infarction reduces cardiac nociceptive neurotransmission through the vagal ganglia
por: Salavatian, Siamak, et al.
Publicado: (2022)

Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI
por: Zhang, Hao, et al.
Publicado: (2022)

Precise dapagliflozin delivery by cardiac homing peptide functionalized mesoporous silica nanocarries for heart failure repair after myocardial infarction
por: You, Lijiao, et al.
Publicado: (2022)

Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI
por: Vilahur, Gemma, et al.
Publicado: (2022)

Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects
por: Harada, Norio
Publicado: (2020)

Rapamycin – “One size does not fit all”
por: Kallijärvi, Jukka, et al.
Publicado: (2019)

Cardiac Troponin I autoantibodies and their potential role in cardiac remodelling
por: Salbach, Christian, et al.
Publicado: (2019)

Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study
por: Carlson, Glenn F., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tkqalsmjnqf7plbq35jsraruth